A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

NCT02990806 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

683

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: NI-071
DRUG: Remicade

Sponsor

Nichi-Iko Pharmaceutical Co., Ltd.